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BOne and Joint Disorders: Prevention and Control
THE AUSTRALIAN ORTHOPAEDIC ASSOCIATION (AOA)
has recently completed implementation of a National Joint
Replacement Registry (AO  NJRR). The purpose of the
Registry is to provide quality demographic information on
the practice of joint-replacement surgery, improve out-
comes, and establish a mechanism of audit for hospitals and
individual surgeons. It is an initiative of the AOA and is
funded by the Federal Government. The Registry is volun-
tary, yet receives cooperation from all hospitals undertaking
joint-replacement surgery. Here, we outline the reasons for
establishing the Registry, some issues related to its imple-
mentation, and examples of early outcomes.
Reasons for establishing the Registry
Changing incidence of joint replacement surgery
Joint replacement surgery is a major area of health expendi-
ture. In 2002, over 50 000 hip and knee replacement
procedures were performed in Australia, at an estimated
cost of well over $500 million. Until recently, the rate of
joint replacement surgery has increased by 5%–10% a year;
the past 2 years have seen increases of more than 10%. The
ageing population and increasing use of joint replacement in
younger people will ensure that this rate of increase will
continue. The number of revision procedures will also
increase as more patients survive longer than the life
expectancy of the replacement joint.
Revision surgery
The outcomes of joint replacement surgery in Australia are
unknown. The requirement for revision surgery is a clear
endpoint which indicates failure, and is therefore a critical
outcome measure.
Currently, in Australia, the percentage of hip replace-
ments that are revision procedures is just over 14%.1 This
probably equates to a revision rate of 20%–24%. Sweden
has had both hip and knee replacement registries for over 20
years; as a consequence the revision rates there are well
defined. The rate for hip replacement surgery in Sweden is
7%.2 Why this difference exists remains to be established,
but it highlights the need to collect information and under-
take appropriate analysis to determine Australia-specific
outcomes.
Reducing the revision rate is a principal focus of the AOA
NJRR. This has been a well established effect of the Swedish
registries.3,4 Revision operations are associated with less
satisfactory outcomes and considerable morbidity and mor-
tality when compared with primary procedures.5-7 Reducing
reoperation is also associated with significant cost savings. A
conservative estimate of savings accompanying a 1% reduc-
tion in the percentage of revision operations is $10 million.
Identifying and publishing outcomes specific to prostheses,
surgical techniques and particular clinical situations is a
critical step to achieving this reduction.
Reasons for revision
The most common reason for revision surgery is aseptic
loosening. This occurs as a result of a localised inflamma-
tory reaction induced by the production of wear particles.
The inflammation results in periprosthetic bone loss, with
consequent component loosening and pain. The extent of
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ABSTRACT
■ In the financial year ending June 2002, 26689 hip 
replacements and 26 089 knee replacements (total, 52 778) 
were performed in Australia.
■ Hip and knee replacement procedures have increased 
between 5%–10% each year for the past 10 years, with a 
combined increase in hip and knee replacement of 13.4% 
in the past year.
■ The revision rate for hip replacement surgery in Australia is 
unknown but is estimated to be 20%–24%; the revision rate 
for hip replacement surgery in Sweden is 7%.
■ Although data collection for the Registry is voluntary, 
it has 100% compliance from hospitals undertaking joint-
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inflammation depends on the number and nature of the
particles produced, which is related to the type of prosthesis
and its positioning, as well as extent of use and time since
implantation. The occurrence of other reasons for revision,
including recurrent dislocation, fracture, infection, ongoing
pain of uncertain aetiology and component breakage, are
also known to vary with the type of prosthesis
Need for postmarketing surveillance
As early as 1993, the AOA identified the need to introduce a
comprehensive postmarketing surveillance program for
joint-replacement prostheses. Currently, in Australia, there
are over 100 different prostheses used for hip replacement
and more than 50 different knee-replacement prostheses.
Because of the rapid introduction of new technologies, the
mid-term and long-term survival rates for the vast majority
of prostheses remain unknown. Inadequate outcome data,
as well as variability of surgical techniques, methods of bone
fixation and clinical situations, make it difficult to determine
the relative effectiveness of different prostheses. These diffi-
culties are further compounded by changes in the perform-
ance of established prostheses resulting from minor design
alterations or changes in the manufacturing process.
Prosthesis recalls
Two recent company-initiated recalls clearly highlighted the
need for the Australian Joint Replacement Registry. Both of
these recalls have been discussed in recent annual reports of
the Registry. The first was the zirconia femoral head recall.1
A problem became evident when a small number of frac-
tures of this ceramic prosthesis were identified in other
countries. A change in the manufacturing process had
altered the ceramic, making it vulnerable to sudden disinte-
gration. This affected several batches of the material. At the
time, it was estimated that almost 9000 patients in Australia
had received the prosthesis.
In the absence of an Australian registry, a number of
difficulties soon became evident. These include:
■ It was not easy to identify patients who had received the
prosthesis. It involved companies going through incomplete
records and individual hospitals examining case notes of
patients who had undergone total hip replacement for the
period that the prosthesis was used. This process was time-
consuming and did not identify all patients.
■ It was not possible to provide ongoing monitoring of
patients who have had a recalled device implanted. It was
known that the number of failures was small, but it was not
known how much the failure rate might increase, or if
different modes of failure might become evident.
The second recall related to a number of prostheses
manufactured by Sulzer Orthopaedics.1 Changes in the
manufacturing process left residual bone-toxic oil-based
lubricant on the prosthesis surface. This was associated with
failure of bone ingrowth and rapid loosening of the prosthe-
sis. Almost 17 000 prostheses were implanted in the United
States before the problem was recognised. Adequate post-
marketing surveillance would have identified the problem
much earlier.
Registry overview
The specific aims of the Registry are to:
■ record demographic and diagnostic information about
patients undergoing joint replacement surgery;
■ provide accurate information on the types of prostheses
used in both primary and revision joint replacements;
■ evaluate the effectiveness of different types of joint
replacement prostheses and surgical techniques;
■ compare the Australian joint replacement data to those of
other countries;
■ provide confidential data to individual surgeons and
hospitals in auditing their joint replacement surgery;
■ educate Australian orthopaedic surgeons in the most
effective prostheses and surgical techniques; and
■ provide a mechanism to enable device tracking of
implanted joint replacement prostheses — in particular,
to rapidly identify patients with an implanted device that
has been subject to recall.
Implementation of the Registry commenced in 1999. This
was undertaken in a staged manner, beginning in South
Australia and then progressing through each state until
national completion in 2002. All 294 hospitals (both public
and private) that undertake hip and knee joint replacement
surgery supply information to the Registry, which is cur-
rently receiving notification of more than 5000 procedures a
month.
The management of the Registry is the responsibility of
the federal board of the AOA through its Registry Manage-
ment Committee. This Committee is responsible for advis-
ing on policy and management decisions, and reports
directly to the board of the AOA. The day-to-day manage-
ment of the Registry is the responsibility of the Director,
who works in close association with the Chairman of the
Registry Committee and the Registry Coordinator. These
AOA appointees meet weekly with personnel from the Data
Management and Analysis Centre at the University of
Adelaide, which manages and analyses the Registry data.
Data, consent and confidentiality
The essential purpose of the Registry dataset is to identify,
by catalogue and lot number, all prosthetic components that
have been implanted into a patient. The dataset is simple,
and includes patient details (name, date of birth, sex, and
address including postcode), hospital, type of procedure
(hip replacement [partial, primary total or revision], knee
replacement [patellofemoral, unicompartmental, primary
total or revision]), side (left or right), diagnosis, and details
(make, catalogue and lot number) of all components used.
Surgeon code can also be used, but this is not compulsory.
Patient consent is obtained using the “opt off” approach.
This requires that patients are provided with information on
the purpose of the Registry, how the information is collected
and an explanation of the simple, cost-free avenues to take
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should patients wish to have their information excluded. To
date, only 5 patients out of 140 000 have elected not to have
their details recorded by the Registry.
No patient, surgeon or hospital is identified in the reports
and publications produced by the Registry. Surgical and
prosthesis data are managed in accordance with the Guide-
lines for the Protection of Privacy in the Conduct of Medical
Research. Personal data collected are for use by the AOA
National Joint Replacement Registry only, and are protected
by the Registry’s listing as a Federal Quality Assurance
Activity.
Data collection and entry
The Registry currently collects information by means of a
paper-based system, with data entered by skilled data entry
personnel. This method was implemented because of its
simplicity and ability to rapidly identify and correct errors in
information provided.
Initial discussions with hospitals indicated that most
would prefer to send the information to the Registry
electronically. However, no hospitals currently collect all the
information required by the Registry on either theatre or
hospital information systems. The Registry has worked
closely with a number of hospitals to develop appropriate
systems for secure electronic data transfer, but the hospital
currently trialling direct electronic entry has raised concerns
about the expense, increased time and reduced accuracy
when compared with the paper-based system.
Data validation
Critical to the success of any registry is the quality control of
the collected information. The AOA NJRR validates its data
by using both internal systems and external data sources.
This process has required continued development and
refinement. The most important external data source is
state health department data. This involves a sequential
multilevel matching process. Registry and state health
department data are initially matched using hospital and
hospital identity number. Subsequent matching is under-
taken on relevant procedure codes and admission period.
This individual patient and procedure validation has been
undertaken for South Australian, Western Australian and
Victorian data used. This process has confirmed that the
initial notification rate to the Registry varies between 95%
and 97% for these three states. The process also identifies
procedures that have not been notified. Direct contact with
the hospitals concerned provides a mechanism for obtaining
missing data, thereby ensuring that data collection
approaches 100% of all procedures.
The Registry is still developing validation procedures for
the individual components used. This will be achieved by
obtaining data from all orthopaedic manufacturing and
distributing companies supplying prostheses in Australia.
Cooperation from companies has been good, and it is
anticipated that the implementation of this additional verifi-
cation mechanism will begin in 2004. Once established,
almost all of the minimum dataset collected by the Registry
will be able to be validated from external data sources.
Early outcomes
Despite the Registry’s short period of existence, it has
already achieved some very important outcomes. It has
shown that it is possible to develop voluntary national
registries within Australia. This has been achieved by
obtaining effective cooperation of federal and state govern-
ments, hospitals, clinicians, nursing and administrative staff
and, most importantly, patients. This, in turn, has been
facilitated by the involvement of the professional body and
providing a clear explanation of the purpose and benefits of
the Registry.
The Registry has quickly established itself as the authori-
tative organisation for information on joint-replacement
surgery. Quality current demographic information is now
freely available to organisations and individuals. Almost
85% of all operations are recorded within 6 weeks, and 95%
within 3 months. Important collaborations involving data
analysis to examine regional differences in availability, effec-
tiveness and true costs of service delivery are being under-
taken.
For the first time, information on the method of fixation
and the types of prostheses used is now available. The
Registry has identified not only major differences in the
practice of joint-replacement surgery between Australia and
other countries, but also significant variation between states
within Australia. An excellent example of this is the use of
cement fixation for both acetabular and femoral compo-
nents in primary total hip replacement. Sweden has an
incidence of cement fixation for both components exceeding
90%, while, in Australia, the incidence is 18.2%, with
variation between 4.5% (New South Wales) and 40.5%
(Queensland).
There are also considerable differences in the use of
prosthetic types. Over 75% of hip replacements undertaken
in Sweden involve the use of five different prostheses. In
Australia, it has become evident that surgeons are mixing
and matching femoral and acetabular components from
different designs and different companies. This is occurring
to such an extent that just under 600 different combinations
of femoral and acetabular components have been recorded
by the Registry.
The critical outcome measure determined by the Registry
is the revision rate. The ability to determine this will be
enhanced with time, as increasing numbers of primary
procedures recorded by the Registry are revised. Despite the
Registry’s short existence, it has already identified specific
prostheses or prosthetic combinations with high early failure
rates. The Allegretto knee, one of the most common
unicompartmental knee-replacement prostheses used in this
country, has a 10% revision rate at 2.5 years, which is
considerably greater than other unicompartmental knee-
replacement prostheses.
The Registry has also identified different outcomes based
on generic features common to a variety of prostheses. An
example of this is the direct relationship between decreasing
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risk of early hip replacement revision with increasing diame-
ter of the head of the femoral component.1
Conclusion
The Registry has already proven to be an important health-
care initiative. It has been able to provide quality demo-
graphic information, determine outcomes, identify both
prostheses that perform well and poorly, as well as establish
a national system for device-tracking of joint-replacement
prostheses. There is no doubt that the Registry’s work will
result in significantly improved outcomes, as well as major
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